Power grading in motor system 1-5

Reading File
Finding Sources
Searching Images

MRC muscle power grading scale 0 to 5 motor system

This diagnostic image set consists of six T1-weighted axial MRI scans of the human thigh, demonstrating the Modified Mercuri scale for grading muscular fatty replacement. The series illustrates a progressive increase in signal hyperintensity within the skeletal muscle compartments, corresponding to adipose tissue infiltration. Score 0 shows normal muscle bulk and signal. Score 1 identifies an 'early moth-eaten' appearance with scattered hyperintense punctate areas. Scores 2 and 3 show increasing confluence of fatty signal, involving <30% and 30-60% of the muscle volume, respectively. Score 4 exhibits a 'faded' appearance with dominant fatty signal, and Score 5 represents end-stage disease where muscle is almost entirely replaced by adipose and connective tissue, with only thin fascia and neurovascular bundles remaining visible. This visual scale is essential for the clinical evaluation of neuromuscular disorders and myopathies, providing a standardized method to quantify disease progression and muscular involution.

This diagnostic image set consists of six T1-weighted axial MRI scans of the human thigh, demonstrating the Modified Mercuri scale for grading muscular fatty replacement. The series illustrates a progressive increase in signal hyperintensity within the skeletal muscle compartments, corresponding to adipose tissue infiltration. Score 0 shows normal muscle bulk and signal. Score 1 identifies an 'early moth-eaten' appearance with scattered hyperintense punctate areas. Scores 2 and 3 show increasing confluence of fatty signal, involving <30% and 30-60% of the muscle volume, respectively. Score 4 exhibits a 'faded' appearance with dominant fatty signal, and Score 5 represents end-stage disease where muscle is almost entirely replaced by adipose and connective tissue, with only thin fascia and neurovascular bundles remaining visible. This visual scale is essential for the clinical evaluation of neuromuscular disorders and myopathies, providing a standardized method to quantify disease progression and muscular involution.

This diagnostic comparison chart illustrates the 3-stage classification system for intraoperative 5-aminolevulinic acid (5-ALA) fluorescence quality grading in neurosurgery, specifically for identifying high-grade glioma margins. The image comprises three side-by-side panels captured under 400 nm violet-blue excitation light. 

- Grade 0 (No fluorescence): Shows a predominantly green/dark background with minimal Protoporphyrin IX accumulation; no distinct pink or purple emission is visible.
- Grade 1 (Weak fluorescence): Displays a subdued, localized purple/pink hue against a dark background, indicating low-level fluorescence that remains transparent enough to see underlying tissue texture.
- Grade 2 (Strong fluorescence): Exhibits intense, vibrant lava-pink or solid purple fluorescence that is opaque and clearly demarcated from surrounding non-fluorescent tissue. 

This scale is a standard neurosurgical tool used during fluorescence-guided resection (FGR) to differentiate tumor tissue from healthy brain parenchyma, aiding in achieving gross total resection of glioblastomas.

This diagnostic comparison chart illustrates the 3-stage classification system for intraoperative 5-aminolevulinic acid (5-ALA) fluorescence quality grading in neurosurgery, specifically for identifying high-grade glioma margins. The image comprises three side-by-side panels captured under 400 nm violet-blue excitation light. - Grade 0 (No fluorescence): Shows a predominantly green/dark background with minimal Protoporphyrin IX accumulation; no distinct pink or purple emission is visible. - Grade 1 (Weak fluorescence): Displays a subdued, localized purple/pink hue against a dark background, indicating low-level fluorescence that remains transparent enough to see underlying tissue texture. - Grade 2 (Strong fluorescence): Exhibits intense, vibrant lava-pink or solid purple fluorescence that is opaque and clearly demarcated from surrounding non-fluorescent tissue. This scale is a standard neurosurgical tool used during fluorescence-guided resection (FGR) to differentiate tumor tissue from healthy brain parenchyma, aiding in achieving gross total resection of glioblastomas.

This clinical photograph displays a telerobotic master device designed for remote orthopedic and neurological assessment. The system serves as a haptic interface for a clinician to evaluate a patient's elbow joint remotely. Key components labeled include a mannequin forearm that mimics the patient's anatomy, which is connected to a mechanical drivetrain. The drive system consists of a brushless DC motor controlled by a motor controller (PUCK). Force transmission is managed through a low-friction, cable-driven speed reduction system featuring Stage 1 and Stage 2 pulley mechanisms. A high-precision torque sensor is integrated to measure the resistance and force feedback during passive range of motion (ROM) tests, muscle strength grading (MRC scale), and spasticity evaluation (Modified Ashworth Scale). The device is utilized in physical therapy and rehabilitation medicine to provide physical interaction between a clinician and a remote environment, enabling functional clinical assessments through bilateral control architecture.

This clinical photograph displays a telerobotic master device designed for remote orthopedic and neurological assessment. The system serves as a haptic interface for a clinician to evaluate a patient's elbow joint remotely. Key components labeled include a mannequin forearm that mimics the patient's anatomy, which is connected to a mechanical drivetrain. The drive system consists of a brushless DC motor controlled by a motor controller (PUCK). Force transmission is managed through a low-friction, cable-driven speed reduction system featuring Stage 1 and Stage 2 pulley mechanisms. A high-precision torque sensor is integrated to measure the resistance and force feedback during passive range of motion (ROM) tests, muscle strength grading (MRC scale), and spasticity evaluation (Modified Ashworth Scale). The device is utilized in physical therapy and rehabilitation medicine to provide physical interaction between a clinician and a remote environment, enabling functional clinical assessments through bilateral control architecture.

Reading File
Reading File
Here is the complete breakdown of the MRC (Medical Research Council) Scale for Motor Power Grading -- directly from Adams and Victor's Principles of Neurology, 12th Edition:

MRC Scale - Motor Power Grading (0-5)

GradeDescription
0Complete paralysis - no contraction whatsoever
1Minimal (flicker/trace) contraction - visible or palpable, but no movement produced
2Active movement only with gravity eliminated (limb can move horizontally on a flat surface)
3Full movement against gravity, but no resistance can be offered against manual opposition
4Active movement against gravity AND resistance, but can be overcome by examiner
5Normal strength - moves against full resistance

Key Clinical Points

Why 6 grades (0-5)? The scale recognizes a clear, clinically meaningful step at each level - from zero neural output to fully intact motor function.
Subdivisions of Grade 4: Because Grade 4 spans a wide range of weakness, it is commonly subdivided in clinical practice:
  • 4- - Movement against gravity + minimal resistance (easily overcome)
  • 4 - Movement against gravity + moderate resistance
  • 4+ - Movement against gravity + strong resistance, barely overcome (near-normal)
Similarly, 3+ and 3- can be used for borderline cases around Grade 3.
How to test properly:
  • Ask the patient to contract the muscle maximally while the examiner opposes with graded resistance (isokinetic method), OR
  • Ask for maximal contraction and try to "break" it (isometric/MVIC method)
  • For Grade 2: position the limb so gravity is eliminated (e.g., test hip abduction in the supine position)
  • Large trunk/girdle muscles may mask slight weakness - supplement with functional tasks (squatting, walking on toes/heels)
Grade 2 vs Grade 3 distinction - this is the gravity threshold: Grade 3 can lift the limb against gravity, Grade 2 cannot.
Grade 4 vs Grade 5 distinction - this is the resistance threshold: Grade 5 is full normal power; Grade 4 can be overcome by an examiner.

Adams and Victor's Principles of Neurology, 12th Ed., "Evaluation of Muscle Weakness and Paralysis"

A patient with tectal plate meningioma with obstructive hydrocephalus was taken for mpvp shunt & post shunt edh happened which was evacuated now the patient has left eye esotropia what could be the differential diagnosis

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Excellent content gathered. Here is the full, structured differential diagnosis:

Left Eye Esotropia Post VP Shunt + EDH Evacuation - Differential Diagnosis

This patient has a layered surgical history (tectal meningioma → obstructive hydrocephalus → VP shunt → post-shunt EDH → EDH evacuation) and now presents with left esotropia. The cause must be interpreted through this entire sequence.

Priority 1: Left CN VI (Abducens) Palsy - Most Likely

The single most important diagnosis to consider.
Left esotropia with limited left eye abduction = left lateral rectus palsy due to CN VI injury.
Why CN VI specifically?
  • CN VI palsy is a classic false localizing sign of raised ICP from any source (hydrocephalus, EDH, shunt dysfunction). It occurs because the abducens nerve stretches over the apex of the petrous bone as the brainstem descends with raised ICP.
  • CN VI palsy can appear after VP shunt insertion itself - specifically documented in Adams and Victor's: "rarely, it may appear after...insertion of a ventricular shunt."
  • The EDH event would have caused acute ICP elevation, further stressing the nerve.
  • In hydrocephalus: "In mild or slowly developing cases, only a sixth-nerve palsy may be seen...hydrocephalus may affect the sixth nerve of one or both eyes" - Neuroanatomy through Clinical Cases.
Clinical pearl: CN VI has the longest intracranial course and is the nerve most vulnerable to any ICP perturbation. Even after successful shunting, the nerve may take weeks to recover.

Priority 2: Shunt Over-drainage / Slit Ventricle Syndrome

After VP shunt placement, over-drainage causes:
  • Traction on cranial nerve roots as the brain sags with low ICP
  • CN VI palsy is the most common cranial nerve manifestation
  • Can paradoxically cause new neurological symptoms despite a working shunt
  • Occurs in ~10% of shunted patients
The low-pressure state post-shunt may have created a hypotensive intracranial environment causing downward traction on the brainstem, stretching CN VI.

Priority 3: Residual/Recurrent Obstructive Hydrocephalus (Shunt Malfunction)

If the shunt is blocked or malfunctioning:
  • Raised ICP reaccumulates
  • The dilated third ventricle/suprapineal recess pushes downward on the tectal plate and collicular plate
  • This directly compresses tectal structures AND stretches CN VI
  • Must be excluded urgently with CT (shunt series + ventricular size assessment)

Priority 4: Direct Tectal/Midbrain Injury - Dorsal Midbrain Syndrome (Parinaud's)

The tectal plate meningioma and surrounding surgical manipulation may have injured the dorsal midbrain (collicular/pretectal region).
Dorsal midbrain syndrome features include:
  • Convergence retraction nystagmus (adducting saccades on attempted upgaze)
  • Tonic convergence spasm - produces esotropia as part of the dorsal midbrain syndrome
  • Supranuclear upgaze palsy
  • Lid retraction (Collier sign)
  • Light-near dissociation
Esotropia from tonic convergence spasm is a recognized component of dorsal midbrain syndrome, relevant here because the tumor itself sits on the tectal plate.

Priority 5: EDH-Related CN VI Traction/Compression

The EDH itself (pre-evacuation) could have caused:
  • Transtentorial herniation with uncal pressure on CN III (causing CN III palsy - but CN III palsy would cause exotropia + ptosis, not pure esotropia)
  • Brainstem displacement stretching CN VI over the petrous ridge
  • Post-evacuation, the nerve may still be recovering

Priority 6: Divergence Paralysis / Acute Acquired Comitant Esotropia (AACE)

  • Esotropia greater at distance than near
  • Associated with severe head injury or raised ICP
  • Bilateral symmetrical esotropia, no true abduction deficit
  • Mechanism: disruption of divergence center (likely in the midbrain/pons)
  • Relevant given the posterior fossa/midbrain involvement in this patient

Priority 7: Midbrain Pseudo-sixth Nerve Palsy

  • A midbrain lesion can mimic CN VI palsy without actual CN VI involvement
  • Produced by internuclear or paramedian pontine reticular formation (PPRF) dysfunction
  • Differentiated from true CN VI palsy by MRI

Priority 8: Post-surgical CN VI Neuropraxia

Direct surgical trauma during:
  • Shunt catheter placement (frontal or parietal approach)
  • Bone work during EDH evacuation
  • Retraction or traction on the base of skull/tentorium

Summary Table

DiagnosisKey FeatureUrgency
CN VI palsy (ICP-related)Limited left abduction, esotropia worse at distanceInvestigate ICP
Shunt over-drainageSymptoms worse upright, low-pressure headacheCT + shunt check
Shunt malfunction / re-raised ICPProgressive symptoms, papilledemaUrgent CT
Dorsal midbrain syndromeUpgaze palsy + convergence spasm + lid retractionMRI brain
AACE / Divergence paralysisComitant ET, worse at distanceMRI brain
Post-surgical CN VI neuropraxiaSubacute onset, may resolveObserve + MRI
Midbrain pseudo-sixth palsyNo abduction deficit on testingMRI midbrain

Recommended Workup

  1. CT brain (urgent) - ventricle size, shunt catheter position, EDH recurrence, residual hematoma
  2. Formal ocular motility exam - is abduction truly limited? (incomitant = CN VI; comitant = central/divergence)
  3. MRI brain with midbrain cuts - tectal plate, periaqueductal grey, CN VI course, petrous apex
  4. Shunt series X-ray - catheter continuity
  5. Fundoscopy - papilledema (raised ICP) vs. no papilledema (over-drainage or direct nerve injury)

Sources: Adams and Victor's Principles of Neurology 12th Ed; Bradley and Daroff's Neurology in Clinical Practice; Neuroanatomy through Clinical Cases 3rd Ed; Localization in Clinical Neurology 8th Ed; Kanski's Clinical Ophthalmology 10th Ed
This is a shared conversation. Sign in to Orris to start your own chat.